SEC Jolts eToro Into Ditching Coins: What It Means For ALGO, MANA, DASH And MATIC

Social investing platform eToro will delist a selection of cryptocurrency tokens for its U.S. customers.

Social investing platform eToro will delist a selection of cryptocurrency tokens for its U.S. customers.

What Happened: The company will no longer allow U.S. customers to open new positions in Algorand (CRYPTO: ALGO), Decentraland (CRYPTO: MANA), Dash (CRYPTO: DASH), and Polygon (CRYPTO: MATIC).

The decision comes in the wake of recent legal action by the U.S. Securities and Exchange Commission (SEC) and illustrates the escalating scrutiny faced by U.S. cryptocurrency exchanges.

However, customers who already hold positions in these tokens will still be able to sell them.

Due to recent developments across “the rapidly evolving regulatory landscape,” eToro confirmed to Benzinga that it will be “making some changes” to its crypto offering starting at 6:00 a.m. ET on Wednesday, July 12.

Also Read: BitGo’s $1.2B Dream Shattered As Mike Novogratz’s Galaxy Digital Wins Court Battle

EToro stated that it remains supportive of crypto assets and acknowledges the importance of offering its users access to a diversified range of asset classes, including stocks, ETFs, and options.

The firm also emphasized its commitment to collaborating with regulators globally to shape the future of the cryptocurrency industry and champion access for ordinary investors.

Why It Matters: EToro’s decision to delist certain tokens should be viewed in the context of the broader regulatory clampdown in the U.S.

The SEC has been actively pursuing legal action against major cryptocurrency exchanges, including Binance (CRYPTO: BNB) for possible violations of securities laws, as well as Coinbase (NASDAQ:COIN) which has been forced to make adjustments to comply with regulations.

Next: Decentralized Lender Puts $100,000 Bounty On Recovering 442 Illicitly Drained Ethereum

Total
0
Shares
Related Posts
Read More

Organigram Reports 16% YoY Revenue Drop But Kicks Off Year ‘With A Bang,’ Says CEO On Hundreds Of Millions In Tobacco Giant BAT Investment

Canadian cannabis producer Organigram reported a 16% decrease in net revenue for Q1 2024 due to a reduction in international revenue and medical sales. The company announced in November that it had received a CA$124.6m ($93m) strategic equity investment from BT DE Investments, a subsidiary of tobacco company British American Tobacco. Organigram shareholders approved the investment in January, and the company completed the first tranche of the investment for $41.5m. CEO Beena Goldenberg said the investment had removed a significant amount of risk from Organigram's business and enhanced its competitive advantages. The investment allows the cannabis producer to utilize its facilities, research and development capabilities, and market leadership to expand its reach within the Canadian market and beyond. Organigram's Q1 financial highlights included a drop in gross margin, an increase in selling and administrative expenses, a net loss of CA$15.8m, and positive adjusted EBITDA of CA$135,000.

BTI